News | May 04, 2026
Moderna posts Q1 2026 loss despite revenue surge
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
The initiative pairs consumer engagement with a public health message about prevention and early detection
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
Tamir brings more than 20 years of experience in the medical technology sector
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis
Health innovations are viewed more positively than food and agricultural technologies
The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder
Subscribe To Our Newsletter & Stay Updated
